How do genetic variants in the UGT1A8 gene influence the treatment response to raloxifene in schizophrenia-spectrum disorders (SSD)?
Label:chem
Topic
The UGT1A8 gene encodes UDP-glucuronosyltransferase 1A8, an enzyme involved in the metabolic pathway of raloxifene. Genetic variants in the UGT1A8 gene may affect the activity of this enzyme and thereby influence the bioavailability and efficacy of raloxifene.
Answer
The study did not find any significant treatment-by-genotype interactions for the UGT1A8 rs1042597 SNP. This suggests that genetic variants in the UGT1A8 gene did not significantly influence the treatment response to raloxifene in this sample of patients with SSD.
Return to Home
Chemical List
Knowledge you may be interested in